PillRx only · Solution · Ophthalmic
Ofloxacin
Ofloxacin
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.198
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
9
Active US suppliers
35%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
92K
Rx · 2026 Q1
595K
Units dispensed
-48%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| A-S Medication Solutions | unknown | 3 | SUPPLYING |
| Proficient Rx LP | unknown | 3 | SUPPLYING |
| Apotex Corp. | unknown | 2 | SUPPLYING |
| St. Mary's Medical Park Pharmacy | unknown | 2 | SUPPLYING |
| Leading Pharma, LLC | unknown | 2 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 2 | SUPPLYING |
| NuCare Pharmceuticals,Inc. | unknown | 1 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Altaire Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 2, 2019RECALLRecall (Class II): Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05
Lack of Assurance of Sterility — Recalling firm: Altaire Pharmaceuticals, Inc. — U.S.A. Nationwide